Medtronic Acquires Nanovis’ Nano-Surface Technology to Enhance Next-Generation PEEK Interbody Fusion Devices

Feb 13, 2025 10:30 CST Updated 10:30

Medtronic

Medical Device Manufacturer

Nanovis

Cervical and Lumbar Interbody Fusion Device Developer

NanovisMedtronic Acquires Nanovis' Nano Surface Technology Assets and Associated Intellectual Property Rights. The new technology acquired by Medtronic will be used in the next generation of PEEK interbody fusion devices from Medtronic. Neither party disclosed the financial terms of the transaction.DisclosureFinancial Terms.

Executive Evaluation

"We are excited about the collaboration with Medtronic. Combining our market-leading nanosurface technology with Medtronic's market-leading PEEK implant design will enable an increasing number of surgeons to use top-tier instruments to treat patients. This partnership underscores the importance of the nanosurface technology we have developed, as well as the value it brings to our customers and patients. Medtronic’s commitment to innovation and commercial scale makes it the ideal partner for bringing these technologies to market."

---Brian More Nanovis CEOOfficial

Nanotechnology refers to the scientific and technological field that studies, designs, manipulates, and applies materials, structures, devices, and systems at the nanoscale (1 to 100 nanometers). Its core lies in utilizing the unique physical, chemical, and biological properties (such as quantum effects, surface effects, etc.) exhibited by substances at the nanoscale to achieve functions or performance unattainable at the macroscopic scale.

NanovisNanovis (Ti Surface) is the first to receive FDA approval for using nanocoating technology on PEEK implant surface modification, and also the world's first to receive FDA approval for nano-modification technology on pedicle screw surfaces.

CurrentlyTi SurfaceAlready applied in 7 spinal field implants (including pure titanium and titanium alloy implants), and since its launch in 2015, more than 10,000 patients globally have received them.Ti SurfaceSurface-Modified Spinal Implants Treatment.

According toNanovisIntroductionNanovis (Ti Surface）With controlled nanostructured surfaces composed of nanotube arrays, the average pore size is between 60-80 nanometers. Compared to other surfaces commonly used in orthopedics, these nanotube arrays have been shown to increase and accelerate the production of calcified extracellular matrix on human osteoblasts and human mesenchymal stem cells in vitro within 21 days.

Ti SurfaceThe technology not only accelerates bone cell growth and the fusion of human tissue with implants, but also has significant economic cost value. According to them,Study: Its cost may be 1/3 to 1/2 of other surface modification technologies (e.g., hydroxyapatite (HAP)), without the various clinical issues associated with hydroxyapatite.

NanovisBy virtue ofTi SurfaceTechnology, by GlobRecognized by al Health and Pharma as the best nanotechnology-driven implant company, and by Med Tech Outlook as one of the top ten orthopedic solution providers.

NanovisIn addition to surface modification technologies, the following spinal implants are also available:

Nanovis

Nanovis is aA technology-driven innovative company dedicated to discovering unmet clinical needs, developing innovative and enabling solutions, and validating new technologies for clinical and market acceptance.Developed a market-leading nanotube surface technology, which has been proven to improve the osseointegration of titanium implants.